RPG Stock Chart & Stats
€0.07
€0.00(0.00%)
At close: 4:00 PM EST
€0.07
€0.00(0.00%)
Day’s Range― - ―
52-Week Range€0.06 - €0.12
Previous CloseN/A
Volume0.00
Average Volume (3M)6.07K
Market Cap
€32.04M
Enterprise Value€41.76M
Total Cash (Recent Filing)€187.97K
Total Debt (Recent Filing)€3.94M
Price to Earnings (P/E)―
Beta1.52
Next Earnings
Sep 01, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.02
Shares Outstanding291,815,800
10 Day Avg. Volume18,212
30 Day Avg. Volume6,070
Financial Highlights & Ratios
PEG Ratio0.94
Price to Book (P/B)-5.41
Price to Sales (P/S)98.99
P/FCF Ratio-8.32
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Free Cash Flow ImprovementAn improving free cash flow trend reduces near-term funding pressure and shows the company can begin to slow cash burn. Over 2–6 months this trajectory gives management more strategic options (cost restructuring, selective investment) and eases immediate refinancing urgency if sustained.
High Gross Margin In 2025A very high gross margin indicates strong unit economics or fee pricing power in the core business. If management can stabilize top-line volumes and control operating costs, this margin base could translate into durable profitability and scalable earnings leverage over the medium term.
Reported Positive Return On EquityPositive ROE suggests the underlying business can generate returns on capital in favorable periods, implying operational competence. If balance sheet issues are resolved, that demonstrated ability to produce returns supports recovery potential and rationalizes efforts to rebuild equity over time.
Bears Say
Negative EquitySustained negative equity materially weakens financial flexibility and raises refinancing and covenant risks. Over the medium term this constrains ability to invest, makes external funding more costly or scarce, and increases the chance of capital raises or restructuring being required to preserve operations.
Persistent Cash BurnConsistent negative operating and free cash flow erodes liquidity and forces reliance on external financing or asset dispositions. Structurally, ongoing cash burn limits the firm's ability to scale, withstand market shocks, or invest in client retention and product development without dilutive or risky funding.
Volatile Revenue And Deteriorating ProfitabilityLarge revenue swings and a worsening net margin indicate unstable fee streams and shrinking operating leverage. This volatility undermines forecasting, client confidence and margin sustainability, making medium-term recovery plans and consistent profitability harder without structural revenue diversification or cost rebalancing.
Endurance RP News
RPG FAQ
What was Endurance RP’s price range in the past 12 months?
Endurance RP lowest stock price was €0.06 and its highest was €0.12 in the past 12 months.
What is Endurance RP’s market cap?
Endurance RP’s market cap is €32.04M.
When is Endurance RP’s upcoming earnings report date?
Endurance RP’s upcoming earnings report date is Sep 01, 2026 which is in 38 days.
How were Endurance RP’s earnings last quarter?
Endurance RP released its earnings results on Mar 26, 2026. The company reported -€0.007 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.007.
Is Endurance RP overvalued?
According to Wall Street analysts Endurance RP’s price is currently Overvalued.
Does Endurance RP pay dividends?
Endurance RP does not currently pay dividends.
What is Endurance RP’s EPS estimate?
Endurance RP’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Endurance RP have?
Endurance RP has 291,815,800 shares outstanding.
What happened to Endurance RP’s price movement after its last earnings report?
Endurance RP reported an EPS of -€0.007 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -5.682%.
Which hedge fund is a major shareholder of Endurance RP?
Currently, no hedge funds are holding shares in DE:RPG
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Endurance RP
Endurance RP Limited functions as an investment holding company, concentrating its investments within the healthcare and life sciences sectors across the People's Republic of China, Europe, Hong Kong, and Taiwan. The firm organizes its activities into two primary divisions: Biopharma and Corporate Investment. The Biopharma segment is responsible for the research, development, production, promotion, and distribution of pharmaceutical products aimed at addressing and managing urological disorders. This division also innovates artificial intelligence systems to precisely track the pace of aging, examining it at molecular, cellular, tissue, organ, systemic, physiological, and psychological levels. Through its Corporate Investment division, the company strategically invests in both publicly traded and privately held corporate entities. Additionally, it extends its services to include management consulting and corporate financial advice. Incorporated in 1991 and headquartered in Central, Hong Kong, Endurance RP Limited adopted its current name in June 2021, having previously operated as Regent Pacific Group Limited.
Technical Analysis
Asia Standard International Group
―
China Innovation Investment Limited
―
Shanghai Realway Capital Assets Management Co., Ltd. Class H
―
Prosperity Investment Holdings Limited
―
Core Economy Investment Group Limited
―